Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus

American Journal of Pathology

Volumn 162, Issue 3, 2003, Pages 747-753

  Klussmann, Jens P ^a,c   Gültekin, Elif ^b   Weissenborn, Soenke J ^a   Wieland, Ulrike ^a   Dries, Volker ^a   Dienes, Hans P ^a   Eckel, Hans E ^a   Pfister, Herbert J ^a   Fuchs, Pawel G ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b GAZI UNIVERSITY   (Turkey)

^c Dept Oto Rhino Laryngol Head/N S ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR MECHANICS; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; TONSIL CARCINOMA; UTERINE CERVIX DYSPLASIA; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; VIRUS TYPING; WART VIRUS;

EID: 0344990170     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63871-0     Document Type: Article

References (41)

1. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994, 264:436-440
2. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366:704-707
3. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994, 368:753-756
4. Li Y, Nichols MA, Shay JW, Xiong Y: Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994, 54:6078-6082
5. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G: Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996, 16:859-867
6. Roussel MF: The INK4 family of cell cycle inhibitors in cancer. Oncogene 1999, 18:5311-5317
7. Kim JW, Namkoong SE, Ryu SW, Kim HS, Shin JW, Lee JM, Kim DH, Kim IK: Absence of p151NK4B and p161NK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection. Gynecol Oncol 1998, 70:75-79
8. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T: Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998, 153:1741-1748
9. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel DM: Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001, 92:276-284
10. Nakao Y, Yang X, Yokoyama M, Ferenczy A, Tang SC, Pater MM, Pater A: Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br J Cancer 1997, 75:1410-1416
11. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996, 56:3630-3633
12. Ambrosch P, Schlott T, Hilmes D, Ruschenburg I: p16 alterations and retinoblastoma protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract. Virchows Arch 2001, 438:343-349
13. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, Hittelman W, Hong WK: Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996, 2:682-685
14. Poi MJ, Yen T, Li J, Song H, Lang JC, Schuller DE, Pearl DK, Casto BC, Tsai MD, Weghorst CM: Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck. Mol Carcinog 2001, 30:26-36
15. El Naggar AK, Lai S, Clayman G, Lee JK, Luna MA, Goepfert H, Batsakis JG: Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol 1997, 151:1767-1774
16. Akanuma D, Uzawa N, Yoshida MA, Negishi A, Amagasa T, Ikeuchi T: Inactivation patterns of the p16 (INK4a) gene in oral squamous cell carcinoma cell lines. Oral Oncol 1999, 35:476-483
17. Gruttgen A, Reichenzeller M, Junger M, Schlien S, Affolter A, Bosch FX: Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers. J Pathol 2001, 194:311-317
18. Klussmann JP, Weissenborn S, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister H, Fuchs P: Prevalence, distribution and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001, 92:2875-2884
19. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709-720
20. Snijders PJ, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ, Walboomers JM: Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 1992, 51:845-850
21. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP: Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997, 79:595-604
22. Brandsma JL, Abramson AL: Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989, 115:621-625
23. Wilczynski SP, Lin BT, Xie Y, Paz IB: Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 1998, 152:145-156
24. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001, 344:1125-1131
25. Klussmann JP, Weissenborn S, Fuchs PG: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001, 345:376
26. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH: Human papillomavirus and risk of oral cancer. Laryngoscope 1998, 108:1098-1103
27. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM: Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001, 92:805-813
28. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E: Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 2000, 89:300-304
29. Klussmann JP, Weissenborn SJ, Wieland U, Eckel HE, Pfister HJ, Fuchs PG: HPV positive tonsillar carcinomas: a different tumor entity?. Med Microbiol Immunol, in press
30. Greene FL, Page DL, Fleming ID, Fritz AG, Blach CM, Haller DG, Morrow M: American Joint Committee on Cancer Staging Manual, ed 6. Berlin, Springer, 2002
31. Pindbord JJ, Reichart PA, Smith CJ, van der Waal I: Histological Typing of Cancer and Precancer of the Oral Mucosa. Berlin, Springer, 1997, pp 11-12
32. de Roda Husman AM, Snijders PJ, Stel HV, van den Brule AJ, Meijer CJ, Walboomers JM: Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 1995, 72:412-417
33. Wieland U, Ritzkowsky A, Stoltidis M, Weissenborn S, Stark S, Ploner M, Majewski S, Jablonska S, Pfister HJ, Fuchs PG: Communication: papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J Invest Dermatol 2000, 115:124-128
34. Boxman IL, Berkhout RJ, Mulder LH, Wolkers MC, Bouwes Bavinck J, Vermeer BJ, ter Schegget J: Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997, 108:712-715
35. Schutze K, Lahr G: Identification of expressed genes by laser-mediated manipulation of single cells. Nature Biotechnol 1998, 16:737-742
36. Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ: The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 1997, 22:176-181
37. Forastiere A, Koch W, Trotti A, Sidransky D: Head and neck cancer. N Engl J Med 2001, 345:1890-1900
38. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001, 93:232-235
39. Peltenburg LT: Radiosensitivity of tumor cells. Oncogenes and apoptosis. Q J Nucl Med 2000, 44:355-364
40. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX: Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002, 21:1510-1517
41. von Knebel DM: New molecular tools for efficient screening of cervical cancer. Dis Markers 2001, 17:123-128